Elisa Jacobsen Pulczynski

Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

Lauren E. Abrey, Tracy T. Batchelor, Andrés J.M. Ferreri et al. · Journal of Clinical Oncology · 2005 · 882 citations

Pcnsl Survivors, Primary Cns Lymphoma, Pathology +17

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2016 · 582 citations · Full text

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2017 · 364 citations · Full text

Neuro-oncology, Radiation Oncology, Lymphoid Neoplasia +12

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · Leukemia · 2022 · 146 citations · Full text

Neuro-oncology, Lymphoid Neoplasia, Transplantation +9

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group

Elisa Jacobsen Pulczynski, Outi Kuittinen, Martin Erlanson et al. · Haematologica · 2014 · 108 citations · Full text

Aging, Disease Progression, Elderly Patients +17